EUROPE— CMR Surgical (CMR), a UK-based global surgical robotics company, has partnered with Kebomed, one of Europe’s largest distributors of specialist medical devices, to introduce the next-generation Versius Surgical Robotic System to Denmark, Norway, and Finland.

Versius, CMR’s system, is a tiny, modular surgical robot that allows hospitals and doctors to perform minimal-access to surgery on patients.

This tiny footprint and lightweight construction allow it to be readily transported between departments, allowing hospitals to maximize its utilization, which can be crucial for many centers implementing new technology.

This declaration comes after the first Versius system was installed in Sweden at the NU-hospital group, a member of Västra Götalandregionen, marking a first for the Nordic region.

Surgical robots have become widely recognized for their use in prostate cancer surgery; nevertheless, they are now being used in a wider range of surgical specialties, including benign and difficult gynaecology, colorectal, and general surgery.

Hospitals have shown that deploying Versius as part of a multi-specialty robotics strategy and converting more cases to minimal access procedures can save up to 450 bed days annually.

Speaking at the ceremony, Henrik Schjødt, CEO and Head of the Board at Kebomed Nordics, emphasized that the Nordic countries are global leaders in responsible healthcare technology introduction, with a focus on quality and cost-effectiveness.

He went on to say that they are excited to collaborate with CMR to bring Versius to their broad portfolio and that the introduction of Versius would provide all surgeons and hospitals with the chance to alter how surgery is performed.

On her part, Susanne Lehnberg, Commercial Manager at CMR Surgical, remarked that this was an exciting step for CMR as they continue to make robotic-assisted surgery more widely accessible to patients across the world.

She was eager to emphasize that they look forward to collaborating with hospitals, surgeons, and surgical teams throughout Denmark, Norway, and Finland to deliver their extremely versatile and digital solutions to the operating room.

Versius has expanded throughout Europe, with over 160 Versius installations worldwide and over 20,000 operations completed in Latin America, Asia Pacific, and the Middle East.

With this achievement, CMR Surgical has received funding from worldwide corporations such as SoftBank and Tencent.

Meanwhile, Dong-A ST, a South Korean pharmaceutical company that manufactures and sells ethical drugs, medical devices, and diagnostic tests, intends to proceed with Versius’ domestic licensing as soon as possible, providing new alternatives to the domestic laparoscopic surgical robot market.

According to the company, the Versius surgical robot, with its great technology, convenience, and proven safety, will improve surgical efficiency and precision for medical professionals.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.